Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,600 signal articles · 209 in last 24h · 117,164 total before filter · latest 24m ago
209last 24h
1673last 7d
267● bullish (7d)
153● bearish (7d)
205publishers
AllMacro317Earnings736M&A96Regulatory27Product12Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How NIKE’s (NKE) Capital Returns Show the Tax Tradeoff Between Dividends and Buybacks
Insider Monkey40d agobullish
How NIKE’s (NKE) Capital Returns Show the Tax Tradeoff Between Dividends and Buybacks

NIKE, Inc. (NYSE:NKE) is one of the dividend stocks picked by financial media as investors ask whether dividend stocks are tax-efficient. On June 30, Nike reported fiscal 2026 fourth-quarter and full-year results and said it returned about $609 million to shareholders through dividends in the fourth quarter, up 3% from the prior year. For fiscal […]

3 Reasons AEIS is Risky and 1 Stock to Buy Instead
StockStory41d agobullish
3 Reasons AEIS is Risky and 1 Stock to Buy Instead

Since July 2021, the S&P 500 has delivered a total return of 74.3%. But one standout stock has more than doubled the market - over the past five years, Advanced Energy has surged 170% to $287.82 per share. Its momentum hasn’t stopped as it’s also gained 36.4% in the last six months thanks to its solid quarterly results, beating the S&P by 27.5%.

Alibaba Jumps Nearly 10% As China AI Stocks Rally
Investor's Business Daily41d agobullish
Alibaba Jumps Nearly 10% As China AI Stocks Rally

U.S.-listed Alibaba Group (BABA) stock jumped nearly 10% in early trading Wednesday, leading a broader rally for China tech and AI stocks. Alibaba stock gained more than 8% to 106 in premarket trades on the stock market today. China search-engine leader Baidu (BIDU) is ahead nearly 5% at 117.38 while Alibaba' e-commerce rival JD.com (JD) climbed 3% to 27.33. Wednesday's...

3 Powerful Nuclear Energy Stocks to Buy in July
24/7 Wall St.41d agobullish
3 Powerful Nuclear Energy Stocks to Buy in July

Nuclear power has shifted from a sleepy utility niche to the most strategically important corner of the energy market. AI-driven electricity demand, hyperscaler power-purchase agreements and an executive-level push to quadruple U.S. nuclear capacity to 400 GWe by 2050 have rewritten the sector’s growth math. The EIA now models commercial data-center server electricity use growing ... 3 Powerful Nuclear Energy Stocks to Buy in July

Vertex Pharmaceuticals (VRTX) Buys Crinetics, Where Does Fair Value Sit Now?
Simply Wall St.41d agobullish
Vertex Pharmaceuticals (VRTX) Buys Crinetics, Where Does Fair Value Sit Now?

Vertex Pharmaceuticals (VRTX) has moved into the spotlight after agreeing to acquire Crinetics Pharmaceuticals for about $10 billion in cash, a rare disease focused deal that immediately broadens its endocrinology footprint. See our latest analysis for Vertex Pharmaceuticals. Vertex Pharmaceuticals' latest share price of US$522.25 sits close to recent highs, with a 30 day share price return of 16.88% and a 1 year total shareholder return of 11.98%, adding to a 163.32% total shareholder return...

Best Buy (BBY) Rolls Out RGB LED TVs, Is The Upside Already Priced In?
Simply Wall St.41d agobullish
Best Buy (BBY) Rolls Out RGB LED TVs, Is The Upside Already Priced In?

Why Best Buy’s RGB LED TV Launch Matters for the Stock Best Buy (BBY) has rolled out RGB LED TVs across nearly all its stores, supported by exclusive partnerships with major TV brands and extensive staff training, creating a differentiated in-store and online offering. For investors watching Best Buy stock, this product launch is tied to a category where millions of households periodically replace TVs, and it comes with integrated services such as free delivery, installation and haul away on...

Is MKS Inc. (MKSI) the Best Stock to Buy in Glen Kacher’s Light Street Portfolio?
Insider Monkey41d agobullish
Is MKS Inc. (MKSI) the Best Stock to Buy in Glen Kacher’s Light Street Portfolio?

MKS Inc. (NASDAQ:MKSI) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. On June 25, 2026, MKS Inc. (NASDAQ:MKSI) announced a $25 million expansion of its Atotech equipment manufacturing facility in Guangzhou, China. The expansion aiming to support the global AI build-out, is expected to be completed before the […]

Advanced Micro Devices (AMD): Top 10 Best Stock to Buy in Glen Kacher’s Portfolio
Insider Monkey41d agobullish
Advanced Micro Devices (AMD): Top 10 Best Stock to Buy in Glen Kacher’s Portfolio

Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. On July 6, 2026, Advanced Micro Devices, Inc. (NASDAQ:AMD) revealed a collaboration with Micro Center, a computer parts retailer. Through the collaboration, the company initiated the global launch of Ryzen AI Halo, a compact system […]

4 Brilliant Vanguard ETFs to Buy in July
24/7 Wall St.41d agobullish
4 Brilliant Vanguard ETFs to Buy in July

July is shaping up as a pivotal month for index investors. The S&P 500 has cooled a bit, with Vanguard S&P 500 ETF (NYSEARCA:VOO) down 1.36% since its year-to-date high on June 2 as the 10-year Treasury yield has eased to 4% and the VIX has settled at 17.65. With the Fed funds rate parked ... 4 Brilliant Vanguard ETFs to Buy in July

AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development
Simply Wall St.41d agobullish
AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development

Certara has announced a partnership with NVIDIA to enhance its AI platform for drug discovery and development by incorporating the NVIDIA BioNeMo Agent Toolkit. This collaboration aims to unify Certara's biosimulation software, regulatory expertise, and datasets with AI-driven agents that provide specialized insights for life sciences. The toolkit enables AI agents to function autonomously, complementing biosimulation models and scientific expertise to accelerate the drug development process...